: A "Dividend King" with 53 consecutive years of increases, AbbVie provides a 3.3% forward yield. Reviewers from The Motley Fool highlight it as a top healthcare choice for 2026 due to its strong pipeline and history of regular payout growth.
: Frequently cited as a "gold standard" for monthly income, this REIT currently offers a 5.2% dividend yield. Analysts at TipRanks have identified it as a top income pick for 2026, supported by its consistent monthly payouts and portfolio of single-tenant commercial properties. fixed income stocks to buy
: A Business Development Company (BDC) offering a substantial 9.5% forward dividend yield, favored for its role in direct lending to mid-sized companies. : A "Dividend King" with 53 consecutive years